SLEEP · 1993 · 104 citations · 11 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyRespiratory PharmacotherapySleep MedicineHypnotic AgentsHypnotic PharmacotherapyHypnotic TherapySleep AssessmentSleep-disordered BreathingSleep-related Breathing DisordersArterial Oxygen SaturationComparative Efficacy Of HypnoticsHypnotic EffectsHypnotic MedicationsNocturnal Oxygen DesaturationPharmacologic Treatment Of InsomniaPharmacological Treatment Of InsomniaSubjective Sleep Measurement
Sleep problems and nocturnal arterial oxygen desaturation are common in patients with chronic obstructive pulmonary disease (COPD). Hence, the safety and efficacy of new hypnotic agents must be ascertained in this group of patients. We performed a double-blind, randomized, single-dose, placebo and active drug controlled, crossover study in 24 patients with insomnia (subjective sleep latency >30 minutes and sleep duration 4–6 hours) and mild to moderate COPD (mean FEV, 61 ± 12(SD)% predicted) in order to establish the effects of Zolpidem 5 mg and 10 mg on sleep and respiration and to compare these effects with triazolam 0.25 mg. Arterial oxygen saturation for the entire night, by hour and by stage, and the apnea-hypopnea index for the entire night were not significantly different with placebo and the various drug conditions. Total sleep time and sleep efficiency were increased over placebo by all three drug conditions. Triazolam was more effective than Zolpidem 5 mg but not Zolpidem 10 mg, and there was no significant difference between Zolpidem 5 mg and zolpidem 10 mg. Zolpidem 10 mg and triazolam both reduced the number of awakenings (> 15 seconds duration) per hour of sleep. Although there was a trend for triazolam to be more efficacious than zolpidem 10 mg, no statistically significant difference was found for any objective or subjective sleep variable. Likewise, Zolpidem 10 mg tended to be more efficacious than Zolpidem 5 mg, but the difference was only significant in terms of perceived sleep quality and ease of falling asleep. In patients with mild to moderate COPD without severe awake resting hypoxemia or hypercapnia, Zolpidem and triazolam in suggested therapeutic doses are safe (with respect to respiration) and effective hypnotics. Zolpidem 10 mg is similar in its hypnotic effect to triazolam 0.25 mg. However, possible individual adverse effects suggest that caution is still required when these hypnotics are prescribed to these patients. Additional caution must be exercised because this study evaluated only a single night of treatment with each dose of sedative, but usually hypnotics are prescribed for more than one night.
11
The effect of oxygenation on sleep quality in chronic bronchitis and emphysema.
P. M. A. Calverley, V Březinová, N J Douglas et al. · PubMed · 1982 · 228 citations
Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease.
W Cormick, L. G. Olson, M J Hensley et al. · Thorax · 1986 · 204 citations · Full text